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Summary
Trafficking of AMPA receptors (AMPA-Rs) to and
from synapses controls the strength of excitatory
synaptic transmission. However, proteins that cluster
AMPA-Rs at synapses remain poorly understood. Here
we show that PSD-95-like membrane-associated gua-
nylate kinases (PSD-MAGUKs) mediate this synaptic
targeting, and we uncover a remarkable functional re-
dundancy within this protein family. By manipulating
endogenous neuronal PSD-MAGUK levels, we find
that both PSD-95 and PSD-93 independently mediate
AMPA-R targeting at mature synapses. We also reveal
unanticipated synapse heterogeneity as loss of either
PSD-95 or PSD-93 silences largely nonoverlapping
populations of excitatory synapses. In adult PSD-95
and PSD-93 double knockout animals, SAP-102 is
upregulated and compensates for the loss of synap-
tic AMPA-Rs. At immature synapses, PSD-95 and
PSD-93 play little role in synaptic AMPA-R clustering;
instead, SAP-102 dominates. These studies establish
a PSD-MAGUK-specific regulation of AMPA-R synap-
tic expression that establishes andmaintains glutama-
tergic synaptic transmission in the mammalian central
nervous system.
Introduction
Glutamate acts on two types of ionotropic glutamate re-
ceptors to mediate excitatory synaptic transmission in
the brain,a-amino-3-hydroxy-5-methyl-4-isoxazole pro-
pionic acid (AMPA) and N-methyl-D-aspartate (NMDA)
receptors. Brief repetitive activation of excitatory synap-
ses leads to long-term changes in synaptic strength
by rapidly redistributing synaptic AMPA receptors
(AMPA-Rs). Such changes may contribute to learning
and memory. However, the proteins involved in AMPA-R
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dense material associated with the postsynaptic mem-
brane, referred to as the postsynaptic density (PSD),
imbeds glutamate receptors. The PSD also contains
scaffolding proteins, some of which contain PSD-95/
Dlg/ZO-1 (PDZ) modular interaction motifs (Kim et al.,
1995; Kornau et al., 1995). A particularly abundant
PDZ-containing protein is PSD-95/SAP-90 (Cho et al.,
1992; Kistner et al., 1993), the prototypical membrane-
associated guanylate kinase (MAGUK). The PSD-95-
like subfamily of MAGUKs (PSD-MAGUKs) includes
PSD-93/Chapsyn-110, SAP-102, and SAP-97. PSD-
MAGUKs share a common domain organization with
three N-terminal PDZ domains, a Src-homology 3 (SH3)
domain, and a carboxy terminal catalytically inactive
guanylate kinase (GK) domain.
Determining whether PSD-MAGUKs play a role in syn-
aptic transmission has been challenging. Whereas the
PDZ domains of PSD-95 bind the C-terminal tails of
NMDA receptor type-2 (NR-2) subunits (Kornau et al.,
1995) and thereby cluster NMDA-Rs (Sheng, 2001), over-
expression of PSD-95 selectively increases synaptic
AMPA-R number (Beique and Andrade, 2003; Ehrlich
and Malinow, 2004; El-Husseini et al., 2000; Nakagawa
et al., 2004; Schnell et al., 2002; Stein et al., 2003). How-
ever, gene-targeted truncation of PSD-95 fails to alter
synaptic transmission mediated either by NMDA recep-
tors (NMDA-Rs) or AMPA-Rs (Migaud et al., 1998).
Several confounding factors may explain these con-
flicting results. PSD-MAGUK overexpression may lead
to artificial protein-protein interactions. In addition, mo-
lecular redundancy among PSD-MAGUKs may lead to
functional compensation, thus confounding the pheno-
type of knockout (KO, or 2/2) mice. To determine
whether PSD-MAGUKs have a role in synaptic function,
we combined experimental approaches. First, we used
short hairpin RNAs (shRNAs) for each PSD-MAGUK
family member to acutely remove endogenous proteins.
We then examined excitatory synaptic transmission in a
complete PSD-95 KO mouse (PSD-952/2) (Yao et al.,
2004), in a complete PSD-93 KO mouse (PSD-932/2)
(McGee et al., 2001), and in a double PSD-95/PSD-93
KO mouse (PSD-952/2/PSD-932/2). Finally, we com-
bined shRNA and overexpression experiments in PSD-
MAGUK KO mice to test directly for functional redun-
dancy and compensation. Taken together our results
indicate that (1) PSD-95 and PSD-93 account for synap-
tic AMPA-R targeting at mature synapses, (2) PSD-95
and PSD-93 determine the synaptic content of AMPA-
Rs at separate, largely nonoverlapping subsets of ex-
citatory synapses, (3) PSD-95 and PSD-93 are jointly
required for normal synaptic expression of NMDA-Rs,
(4) SAP-102 functionally compensates for PSD-95
and PSD-93 in AMPA-R and NMDA-R trafficking in the
PSD-952/2/PSD-932/2 mouse, and (5) the role of PSD-
MAGUK proteins in synaptic AMPA-R targeting is de-
velopmentally regulated; SAP-102 is primarily respon-
sible for clustering in neonatal synapses, whereas
PSD-95 and PSD-93 primarily anchor proteins in mature
synapses.
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lated proteins represents a recurring and challenging
theme in modern biology. This study establishes novel
experimental paradigms that can be broadly applied to
unravel this knotty problem.
Results
shRNA Interference of PSD-MAGUKs
We first generated shRNAs against PSD-95, PSD-93,
and SAP-102 and tested their efficiency and specificity
by coexpression with cDNA expression vectors in
COS-7 cells (Figure 1A). Knockdown of PSD-MAGUK
expression was strictly specific and protein amounts
were reduced below detection for each of the PSD-
MAGUKs. Introducing silent point mutations in the rele-
vant cDNAs prevents the knockdown, demonstrating
target specificity (Figure 1B).
We used western blot analysis to measure the effect
of shRNA on the level of PSD-MAGUK protein in primary
hippocampal cultures infected with shRNA-containing
Lentivirus (Figure 1C) (Lois et al., 2002). shRNA expres-
sion selectively reduced PSD-95, PSD-93, or SAP-102
protein. Lentivirus expressing a control shRNA se-
quence had no effect. As the infection efficiency was
w70%, these results underestimate the knockdown ef-
ficiency in infected cells. We confirmed the quantitative
loss of PSD-95 protein in individual neurons by immuno-
cytochemistry (see Figure S1 in the Supplemental Data).
shRNA of SAP-97 dramatically blocked expression of
SAP-97 in COS-7 cells (not shown). However, we were
unable to reduce SAP-97 protein in neuronal cultures.
We tried two different shRNA constructs that were
Figure 1. shRNAs Against PSD-95, PSD-93, and SAP-102 Cause
Selective Knockdown in COS-7 Cells and Hippocampal Neurons
(A) COS-7 cells were cotransfected with expression vectors for PSD-
95, PSD-93, or SAP-102 (wt cDNA) and an shRNA vector targeting
each protein, respectively. shRNAs eliminated detectable protein
for the targeted family member without affecting the other two
PSD-MAGUKs.
(B) This knockdown was prevented by silent point mutations in the
cDNAs of the targeted family member (pm cDNA). Control shRNA
vector had no effect.
(C) Dissociated hippocampal neurons were infected with Lentivirus
(w70% efficiency) containing shRNA against PSD-95, PSD-93,
SAP-102, or control sequence. Protein levels of PSD-95, PSD-93,
or SAP-102 are reduced by corresponding shRNAs in comparison to
control virus. NR-1 and Tubulin expression levels were unchanged.effective in COS-7 cells, and we tested multiple SAP-
97 antibodies (data not shown). Thus, we are unable to
address the consequences of SAP-97 deletion on syn-
aptic transmission.
shRNA Knockdown and Gene-Targeted Deletion
of PSD-95
We first examined the effect of PSD-95 shRNA. As
shown in Figure 2A, surface GluR2 puncta localized at
synaptic spines were greatly reduced in cultured disso-
ciated neurons (DIV 19–21) expressing PSD-95 shRNA
(42% of control). This decrease occurred without chang-
ing the density of dendritic spines (Figure 2B). Total sur-
face GluR2 expression was effected to a similar degree
(n = 9 cells in each condition; control = 15.9 6 1.2 and
PSD-95 shRNA = 8.2 6 1.7 clusters per 10 mm of den-
drite, p < 0.01). We used hippocampal slice cultures (Fig-
ures 2C–2I) to examine the effects on synaptic function.
Two to three days after preparation, slices were infected
with PSD-95 shRNA-carrying Lentivirus and were left for
a further 5–8 days. We simultaneously recorded from an
infected neuron and an uninfected neighbor and com-
pared the synaptic responses evoked by a common
input. A typical experiment is shown by the traces in
Figure 2C1. As reported previously (Nakagawa et al.,
2004), the AMPA-R component of the excitatory post-
synaptic current (EPSC) was dramatically decreased in
the infected cell, whereas there was no difference in
the NMDA-R component. The results, shown in scatter
plots for all neuronal pairs (Figures 2C2 and 2C3), dem-
onstrate a 51% decrease in the size of the AMPA-R
EPSC (Figure 2C2). On the other hand, there is no
change in the size of the NMDA-R EPSC (Figure 2C3).
These effects are target-specific, as repeating the ex-
periment in slice cultures made from PSD-952/2 mice
(see below) did not change either the AMPA-R (Fig-
ure 2D2) or NMDA-R EPSC (Figure 2D3). Also, using
a control shRNA sequence did not effect the AMPA-R
EPSC (uninfected: 49.1 6 6.8 pA; infected: 41.9 6 6.5
pA; n = 16, p = 0.29) (data not shown). Slow turnover of
PSD-95 does not explain the remaining AMPA-R
EPSC, as waiting 12–14 days after infection led to no fur-
ther reduction (uninfected: 62.5 6 5.9 pA; infected:
26.2 6 3.5 pA; n = 12, p < 0.0001) (data not shown).
To understand the basis for the reduction in AMPA-R
EPSCs, we first evaluated miniature EPSCs (mEPSCs)
(Figures 2E–2G). In PSD-95 shRNA-infected neurons,
there was no change in amplitude (Figure 2F) but a large
decrease in event frequency (Figure 2G), suggesting that
a population of synapses is silenced. To ensure that a
reduction in mEPSC amplitude could be observed,
we reduced evoked EPSCs to a similar extent with
the AMPA-R antagonist NBQX. With NBQX, a clear
reduction in mean amplitude was observed (control:
215.1 6 1.2 pA, n = 8; NBQX: 28.6 6 1.2 pA, n = 3; p <
0.05) (data not shown). To monitor silent synapses di-
rectly, we carried out minimal stimulation experiments
to compare the incidence of failures in control and in-
fected cells (Figure 2H); failure rates were consistently
enhanced in the infected cells.
Where do AMPA-Rs go after they have been removed
from the synapse by shRNA PSD-95? Previous ex-
periments suggest that overexpression of PSD-95 re-
cruits AMPA-Rs from extrasynaptic membranes to the
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shRNA causing redistribution from synapses to extrasy-
naptic membranes, we found that the size of AMPA-R-
mediated currents in outside-out somatic (nonsynaptic)
membrane patches was enhanced (Figure 2I).
Conflicting with our shRNA data, targeted truncation
of PSD-95 in mice has no effect on synaptic transmission
(Migaud et al., 1998). Might the difference be due to the
remaining expression of the N-terminal fragment of
PSD-95 in this mouse (Migaud et al., 1998), which is nec-
essary and sufficient for the overexpression enhance-
ment (Schnell et al., 2002)? To address this, we examined
synaptic transmission in acute hippocampal slices from
postnatal day 30 to 40 (P30–40) mice that completely lack
PSD-95 protein (Yao et al., 2004) (Figures 2J and 2K).
First, we used extracellular field potential recording to
compare the strength of synaptic transmission between
control and PSD-952/2mice. The size of the presynaptic
fiber volley (input) was compared to the size of the field
excitatory postsynaptic potential (fEPSP) response (out-
put). Over a range of stimulus strengths, no differences
were observed between PSD-952/2 and control mice
(Figure 2J). Next, we compared the size of the AMPA-R
EPSC to that of the NMDA-R EPSC. In contrast to our
shRNA experiments, we found no difference in the
AMPA/NMDA EPSC ratio (Figure 2K), indicating that syn-
aptic transmission is normal in the PSD-952/2 mouse.
Effects of shRNA Knockdown and Gene-Targeted
Deletion of PSD-93
Do other PSD-MAGUKs play a role in glutamate receptor
synaptic clustering? We examined the role of PSD-93,
which also localizes to dendritic spines in CA1 hippo-
campal pyramidal neurons (Figure 3A). PSD-93 overex-
pression strongly enhances AMPA-R EPSCs (Figures
3B1 and 3B2). This enhancement was receptor-selec-
tive, as there was no change in NMDA-R EPSCs (Figures
3B1 and 3B3). In addition, shRNA knockdown of PSD-93
caused a 48% selective reduction in the size of the
AMPA-R EPSC (Figures 3C1 and 3C2), with no change
in NMDA-R EPSCs (Figures 3C1 and 3C3). This effect
on AMPA-R transmission is target-specific; repeating
the same experiment in the PSD-932/2mouse had no ef-
fect (Figures 3D1–3D3). We examined the mechanism
for this reduction by recording mEPSCs. Similar to the
results with PSD-95 shRNA, depletion of PSD-93 had
no effect on the amplitude of mEPSCs (Figures 3E and
3F), but did cause a clear reduction of the frequency of
mEPSCs (Figure 3G), suggesting that AMPA-Rs are
lost from a subset of synapses.
We also analyzed synaptic transmission in the hippo-
campus of the PSD-932/2 mouse (McGee et al., 2001).
We first used field potential recordings to evaluate the
strength of synaptic transmission. No difference in syn-
aptic strength was found (Figure 3H). Next we examined
the relative contribution of AMPA and NMDA receptors
to the synaptic response (Figure 3I); again, no difference
could be detected.
The Effects of Gene-Targeted Double Knockout
of PSD-95 and PSD-93 on Synaptic Transmission
As shRNA to either PSD-95 or PSD-93 diminish synaptic
targeting of AMPA-Rs, perhaps functional redundancy
masks synaptic deficits in the single KO mice. To ad-dress this, we generated PSD-95/PSD-93 double KOs.
Unlike the single KOs, which were grossly indistinguish-
able from their littermates, PSD-952/2/PSD-932/2 mice
were clearly impaired. By 3 to 5 weeks of age, these an-
imals were noticeably smaller than control littermates
(Figure 4A) and typically died unless special care was
provided from weaning onward. The animals had im-
paired gait and were markedly hypokinetic (see Movie
S1 in the Supplemental Data). In these animals, field
input/output curves revealed a 55% reduction in synap-
tic transmission (Figure 4B). Furthermore, the AMPA/
NMDA EPSC ratio was reduced w50% (Figure 4C).
These decreases occurred without any change in paired
pulse facilitation (PPF) (Figure 4G), indicating that the
probability of transmitter release was unaltered. Inter-
estingly, as with shRNA knockdown of PSD-95 or
PSD-93, the amplitude of mEPSCs was unchanged (Fig-
ures 4D and 4E), but there was a dramatic reduction in
the frequency (Figures 4D and 4F).
Western blotting of PSD-952/2/PSD-932/2 hippocam-
pal homogenates and littermate controls showed no dif-
ference in the total amounts of GluR1, GluR2, and NR-1
(Figures 4H and 4I). However, in accord with the electro-
physiological data, the PSD-enriched fraction (TritonX
100 insoluble) showed a significant loss of GluR1
and GluR2 (Figures 4J and 4K), while NR-1 remained
unchanged.
Role of SAP-102 in Synaptic Transmission
What might account for the remaining transmission
in the PSD-952/2/PSD-932/2 mice? As this remaining
transmission greatly exceeds the subtractive effects of
the combined individual shRNA-mediated knockdowns,
some type of compensation has presumably occurred.
Might other PSD-MAGUKs contribute to clustering syn-
aptic AMPA-Rs? We first carried out western blotting on
hippocampal homogenates from PSD-952/2/PSD-932/2
mice and found no change in the total level of SAP-97,
whereas SAP-102 expression was increased by about
20% (Figure 5A). Similar results were obtained for the
PSD-enriched fraction (Figure 5B). These results sug-
gest that SAP-102 may cluster the AMPA-Rs that medi-
ate the remaining synaptic transmission.
Previous studies showed that overexpression of SAP-
102 selectively enhances AMPA-R EPSCs (Schnell et al.,
2002). However, in the present study we found that
knockdown of endogenous SAP-102 with shRNA had
no effect on basal synaptic transmission (Figures 5C1–
5C3), indicating that SAP-102 is not required for synap-
tic AMPA or NMDA receptor expression at mature
synapses. In striking contrast SAP-102 shRNA expres-
sion in slice cultures from PSD-952/2/PSD-932/2 mice
caused a 52% reduction in the remaining transmission
(equivalent to 82.5% from wild-type) (Figures 5D1 and
5D2). There was also a small reduction in the NMDA-R
component (Figure 5D3). No change in PPF was de-
tected (Figure 5E), indicating a postsynaptic change.
Concomitant with the reduction in evoked synaptic
transmission, AMPA-R-mediated mEPSC amplitude
was decreased and frequency was further decreased
(Figures 6A–6C), suggesting removal of AMPA-Rs from
all of the remaining synapses.
The depression of the NMDA-R EPSC is the first func-
tional evidence that PSD-MAGUKs may, in fact, play
Neuron
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(A) Dissociated rat hippocampal neurons infected with GFP (to visualize spine structure) and shRNA against PSD-95 showed a significant reduc-
tion in surface GluR2 (sGluR2) clusters compared with neurons infected with GFP only. Scale bar, 5 mm.
(B) The number of sGluR2-positive spines in PSD-95 shRNA infected neurons was reducedw50% (right panel) with no effect on total spine num-
ber (n = 9 cells for each condition, *p < 0.05). Error bars = SEM.
(C1–D3) For scatter plots, open circles represent amplitudes for single pairs and filled circles represent the mean6 SEM. (C1) Traces of evoked
EPSCs recorded simultaneously from an uninfected wild-type neuron (top) and a neighbor infected with PSD-95 shRNA Lentivirus (middle). Dis-
tributions of EPSC amplitudes show a significant reduction in the AMPA-R EPSC (C2) but no change in the NMDA-R EPSC (C3). (D1) Traces of
simultaneously recorded evoked EPSCs in pyramidal neurons from PSD-952/2 mice showing that PSD-95 shRNA expression has no effect on
AMPA-R (D2) or NMDA-R (D3) EPSCs. (C1) and (D1) scale bars, 50 pA, 50 ms.
(E–G) mEPSC sample traces ([E], scale bar: 20 pA, 250 ms) showing that shRNA-mediated knockdown of PSD-95 does not affect the mEPSC
amplitude ([F], n = 9 pairs) but strongly reduces mEPSC frequency ([G], n = 15 pairs). Error bars = SEM.
(H) (Top) Superimposed traces showing responses to minimal stimulation from a control uninfected cell (left) and a PSD-95 shRNA-expressing
cell (right). Scale bar, 25 pA, 10 ms. (Bottom) Pairwise comparison reveals a significantly larger incidence of failures in PSD-95 shRNA infected
cells (uninfected: 27.3% 6 8.5%; infected: 65.2% 6 10%; n = 6 pairs, *p < 0.05).
(I) (Top) Traces of AMPA-evoked currents from outside-out somatic patches in uninfected control and PSD-95 shRNA-expressing cells. Scale
bar, 250 pA, 1 s. (Bottom) PSD-95 knockdown significantly increases extrasynaptic AMPA-R responses (uninfected: 461.6 6 46.1, n = 11;
infected: 717.2 6 62.7, n = 5; *p < 0.05). Error bars = SEM.
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expected finding, we wished to ensure that this effect
was not nonspecific. Therefore, we compared the effect
of SAP-102 shRNA on the AMPA-R EPSC and the inhib-
itory postsynaptic current (IPSC) in slices from PSD-
952/2/PSD-932/2 mice. In the presence of the NMDA-
R blocker APV, we measured the size of the AMPA-R
EPSC at 260 mV, the reversal potential for the IPSC,
and then measured the size of the IPSC at 0 mV, the re-
versal potential for the EPSC. The depression of the
AMPA-R EPSC by SAP-102 shRNA was not accompa-
nied by any change in the IPSC (Figures 6D1–6D3).
These experiments, as well as the fact that SAP-102
shRNA in mature wild-type mouse slices had no effect,
establish the specificity of the effects on both the
AMPA-R and NMDA-R EPSCs.
Our results show that shRNA-mediated knockdown of
either PSD-95 or PSD-93 results in anw50% reduction
in the AMPA-R EPSC. In PSD-952/2/PSD-932/2 mice,
AMPA-R-mediated transmission is reduced by 55%. In
these mice, SAP-102 is upregulated and is responsible
for targeting much of the remaining AMPA-Rs. Taken to-
gether, these results suggest that PSD-95 and PSD-93
determine the synaptic expression of most, if not all,
AMPA-Rs. Accordingly, simultaneous knockdown of
PSD-95 and PSD-93 should reduce transmission by sig-
nificantly more than 50%. To test this, we infected wild-
type slices with Lentiviral particles expressing PSD-95
shRNA and dsRed in parallel with particles expressing
PSD-93 shRNA and EGFP. A substantial number of cells
expressed both constructs (Figure 7A). In doubly in-
fected cells AMPA-R-mediated synaptic transmission
was reduced w75% (Figures 7B1 and 7B2). Note that
there is also a reduction in the NMDA-R component ac-
companying the dramatic loss of AMPA-Rs (Figure 7B3).
No significant change in PPF was detected (control:
1.6 6 0.1; infected: 2.0 6 0.2; n = 15, p = 0.07, data not
shown), suggesting an entirely postsynaptic effect.
These results with acute double shRNA are more dra-
matic than in the PSD-952/2/PSD-932/2 mouse, but re-
semble results obtained with SAP-102 shRNA in the
PSD-952/2/PSD-932/2 background. To ensure that the
effects caused by the double shRNA are specific, we re-
peated these experiments in slices from PSD-952/2/
PSD-932/2 mice (Figures 7C1–7C3). No effect was ob-
served, indicating the specificity of the results in the
wild-type slices. Taken together, these results strongly
suggest that (1) when PSD-MAGUKs are deleted in the
germ line, other PSD-MAGUKs can compensate, and
(2) PSD-MAGUKs are essential for targeting nearly all
AMPA-Rs to the synapse.
PSD-MAGUK-Specific Developmental Regulation
of Synaptic AMPA-R Targeting
During development SAP-102 is expressed strongly by
P10, whereas robust expression of PSD-95 and PSD-
93 occurs 3 weeks later (Sans et al., 2000). The impair-
ment in PSD-952/2/PSD-932/2 mice (Figure 4) matchedthis developmental expression profile. Thus, 1 week old
PSD-952/2/PSD-932/2 mice were indistinguishable
from their littermates (Figure 8A). Moreover, 1 week old
PSD-952/2/PSD-932/2 mice showed no difference in
the AMPA/NMDA ratio (Figure 8B), mEPSC amplitude
(Figures 8C and 8D), or mEPSC frequency (Figure 8E).
Furthermore, shRNA knockdown of PSD-95 did not
affect synaptic transmission in immature synapses
(Figures 8F1–8F3). Whereas SAP-102 shRNA had no
effect on mature synapses (Figures 5C1–5C3), SAP-
102 shRNA caused an w50% reduction specifically in
AMPA-R-mediated synaptic transmission in immature
synapses (Figures 8G1–8G3). This establishes SAP-
102 as the dominant PSD-MAGUK for AMPA-R traffick-
ing during early postnatal development.
Discussion
These results provide important new mechanistic in-
sights into synaptic AMPA-R targeting. They also com-
pare the utility of two widely used loss-of-function
approaches—gene targeting and RNA interference
(RNAi)-mediated knockdown. Acute knockdown with
shRNA shows that PSD-95 and PSD-93 normally medi-
ate AMPA-R targeting to mature synapses. Interestingly,
these knockdowns silence a population of synapses and
have no effect on the remaining synapses, which indi-
cates unexpected synaptic heterogeneity. Mice geneti-
cally lacking either PSD-95 or PSD-93 show little defect
in synaptic transmission. This reflects redundancy, as
PSD-952/2/PSD-932/2 mice show a clear defect. SAP-
102 has no role at mature synapses, but is upregulated
in the PSD-952/2/PSD-932/2 mouse to mediate residual
transmission. At immature synapses, PSD-95 and PSD-
93 play a minor role, whereas SAP-102 is primarily re-
sponsible for synaptic targeting of AMPA-Rs. Our re-
sults show a remarkable orchestration by PSD-MAGUKs
in synaptic trafficking of AMPA-Rs.
Overexpression of PSD-MAGUKs
In a previous study, we reported that overexpression of
PSD-95 and SAP-102 enhanced AMPA-R EPSCs, while
overexpression of SAP-97 had no effect (Schnell et al.,
2002). Similar results with PSD-95 have been reported
(Beique and Andrade, 2003; Ehrlich and Malinow,
2004; Nakagawa et al., 2004). More recent studies
have reported that SAP-97 overexpression causes
a modest enhancement of EPSCs both in slice culture
(Nakagawa et al., 2004) and in dissociated neurons
(Rumbaugh et al., 2003). What might account for the dif-
ferent results? In one study it was found that only one
splice variant of SAP-97 caused the enhancement in
EPSCs (Rumbaugh et al., 2003). However, we used this
variant in our past and present experiments, which in-
volved expressing the untagged wild-type construct
(data not shown). In a final set of experiments we found
that PSD-93 selectively enhanced AMPA-R EPSCs. In
summary, based on our experiments, overexpression(J) (Top) Traces of AMPA-R-mediated field responses recorded from acute hippocampal slices from PSD-952/2 and control mice. Scale bar,
0.5 mV, 5 ms. (Bottom) Input-output curve showing that for each input (FV, fiber volley), the output (fEPSP) is unchanged in the PSD-952/2 relative
to controls. Each point represents the mean 6 SEM for each fiber volley (controls, n = 56; PSD-952/2, n = 26; p > 0.05 for all fiber volleys).
(K) (Top) NMDA-R and AMPA-R EPSCs from PSD-952/2 and controls. Scale bar, 25 pA, 50 ms. (Bottom) Bar graphs showing no difference in the
AMPA/NMDA EPSC ratio (controls: 0.69 6 0.04, n = 40; PSD-952/2: 0.69 6 0.08, n = 20; p = 0.94). Error bars = SEM.
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(A) Fluorescent image showing appropriate targeting of GFP-PSD-93 fusion protein to dendritic spines (inset, red arrow). Scale bar, 50 mm.
(B1–D3) Open and filled circles represent amplitudes for single pairs and mean6 SEM, respectively. (B1) Traces of evoked EPSCs recorded si-
multaneously from an uninfected neuron (left) and a neighbor overexpressing PSD-93 (middle). Distributions show enhancement in the AMPA-R
EPSC (B2) but no change in the NMDA-R EPSC (B3). (C1) Traces of evoked EPSCs from an uninfected neuron (left) and a neighbor expressing
PSD-93 shRNA (middle). Distributions show a reduction in the AMPA-R EPSC (C2) but no change in the NMDA-R EPSC (C3). (D1) Traces showing
that PSD-93 shRNA expression in neurons from PSD-932/2mice has no effect on AMPA-R (D2) or NMDA-R (D3) EPSCs. Scale bars for (B1), (C1),
(D1), 50 pA, 50 ms.
(E–G) mEPSC traces ([E], scale bar, 25 pA, 250 ms) showing that shRNA-mediated knockdown of PSD-93 does not affect mEPSC amplitude ([F],
n = 15) but does reduce frequency ([G], n = 15). Error bars = SEM.
(H) Sample traces of field responses recorded from PSD-932/2 and controls. Scale bar, 0.5 mV, 5 ms. Input-output curve showing that for each
fiber volley the fEPSP is unchanged in PSD-932/2 (controls: n = 56; PSD-932/2: n = 16). p > 0.05 for every fiber volley. Error bars = SEM.
(I) Sample NMDA-R and AMPA-R EPSCs from representative cells. Scale bar, 25 pA, 50 ms. (Right) Bar graphs showing no difference in the
AMPA/NMDA EPSC ratio (control: 0.69 6 0.04, n = 40; PSD-932/2: 0.7 6 0.08, n = 11; p = 0.92). Error bars = SEM.of PSD-95, PSD-93, and SAP-102, but not SAP-97,
robustly and selectively enhances AMPA-R EPSCs.
However, it has remained unclear whether these find-
ings, based on overexpression, have any physiological
relevance.shRNA Knockdown of PSD-MAGUKs
Our generation of shRNAs that selectively and dramati-
cally knock down expression of PSD-95, PSD-93, and
SAP-102 allowed us to address this issue. Knockdown
of either PSD-95 or PSD-93 resulted in a selective 50%
PSD-MAGUKs Regulate AMPA-R Synaptic Trafficking
313Figure 4. Impaired AMPA-R-Mediated Synaptic Transmission in PSD-95/PSD-93 Double KO Mice
(A) P32 PSD-952/2/PSD-932/2 and PSD-95+/2 /PSD-932/+ littermates (U.S. dime shown for size reference).
(B) (Top) Traces of AMPA-R-mediated field responses recorded from PSD-952/2/PSD-932/2 and controls. Scale bar, 0.5 mV, 5ms. (Bottom)
Input-output curve showing a reduction in the input-output relation in PSD-952/2/PSD-932/2 (controls: n = 56; PSD-952/2/PSD-932/2: n = 15;
p < 0.05 for FV = 0.2–0.6).
(C) (Top) NMDA-R and AMPA-R EPSCs recorded in pyramidal neurons from PSD-952/2/PSD-932/2 and controls. Scale bar, 25 pA, 50 ms. (Bot-
tom) AMPA/NMDA EPSC ratio bar graphs showing a reduction in PSD-952/2/PSD-932/2 mice (control: 0.69 6 0.04, n = 40; PSD-952/2/
PSD-932/2: 0.34 6 0.04, n = 8; ***p < 0.001).
(D–F) mEPSC sample traces ([D], scale bar, 25 pA, 250 ms) and cumulative probability distributions showing no change in mEPSC amplitude (E)
but a significant reduction in mEPSC frequency (F) in PSD-952/2/PSD-932/2 mice (control: n = 16; PSD-952/2/PSD-932/2: n = 13).
(G) PPF sample traces (top; scale bar: 0.25 mV, 10 ms) and summary (bottom) showing no difference between PSD-952/2/PSD-932/2 and con-
trols (controls: 1.3 6 0.06, n = 21; PSD-952/2/PSD-932/2: 1.28 6 0.06, n = 17; p = 0.97).
(H and I) Total glutamate receptor levels in PSD-952/2/PSD-932/2 mice are unchanged. Western blotting of SDS-solubilized homogenates of
PSD-952/2/PSD-932/2and littermate controls reveals no difference in total NR-1, GluR1, or GluR2/3 levels (n = 4).
(J and K) In TritonX 100 insoluble, PSD-enriched membrane fraction, GluR1 and GluR2/3 are reducedw30%, whereas there is no change in NR-1
(n = 3, *p < 0.05).
Error bars = SEM.
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(A) SAP-102 protein level increases in hippocampal homogenates of 4 week old PSD-952/2/PSD-932/2 (n = 4, *p < 0.05).
(B) Elevated amount of SAP-102, but not SAP-97, in TritonX 100 insoluble, PSD-enriched fraction from PSD-952/2/PSD-932/2 hippocampal
membranes. NR-1 is shown as a loading control (n = 3, *p < 0.05).
(C1–D3) Open and filled circles represent amplitudes for single pairs and mean 6 SEM, respectively. (C1) Traces of evoked EPSCs from an un-
infected wild-type neuron (top) and a neighbor expressing SAP-102 shRNA (middle). Distributions of EPSCs show no effect of SAP-102 shRNA
expression on AMPA-R EPSCs (C2) or NMDA-R EPSCs (C3). (D1) Traces of EPSCs in pyramidal neurons from PSD-952/2/PSD-932/2mice show-
ing that SAP-102 knockdown reduces the AMPA-R EPSC (D2) and modestly reduces the NMDA-R EPSC (D3). Scale bars for (C1) and (D1), 25 pA,
50 ms.
(E) PPF [sample traces, left (scale bars: 10 pA, 25 ms); and summary bar graphs, right] was not affected by SAP-102 shRNA expression in neurons
from PSD-952/2/PSD-932/2 mice (uninfected: 2.0 6 0.06, n = 21; infected: 1.9 6 0.09, n = 21; p = 0.16).
Error bars = SEM.reduction in the AMPA-R EPSC. These effects were spe-
cific, as a control shRNA construct had no effect, and
expressing the PSD-95 or PSD-93 shRNAs in the PSD-
952/2 or PSD-932/2 mice, respectively, were without
effect. Interestingly, knockdown of PSD-95 or PSD-93
completely removed AMPA-Rs from largely nonoverlap-
ping subpopulations of synapses without affecting the
remaining synapses. This finding indicates heterogene-
ity among excitatory synapses. The nature of the hetero-
geneity is not obvious, because immunocytochemistry
in dissociated neurons demonstrates that PSD-95 and
PSD-93 puncta closely colocalize, and virtually all
excitatory synapses in cells expressing shRNA for
PSD-95 lack PSD-95 staining, but do stain for PSD-93
(Figure S1). However, electron microscopic immuno-gold studies have shown that colocalization of PSD-95
and PSD-93 is much lower in vivo (w30%) than that ob-
served in vitro (>90%; Sans et al., 2000). Thus, it could be
envisaged that AMPA-Rs are removed from synapses
only when the level of PSD-MAGUKs falls below a critical
threshold, and that in those synapses that remain unal-
tered in a single shRNA experiment, the unaffected
PSD-MAGUK is above threshold levels. shRNA knock-
down of SAP-102 had no significant effect on synaptic
transmission at mature synapses, indicating that both
PSD-95 and PSD-93, but not SAP-102, play an important
role in maintaining AMPA-Rs at mature excitatory
synapses.
Our findings show that shRNA-mediated knockdown
of either PSD-95 or PSD-93 results in an w50%
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(A–C) AMPA-R-mediated mEPSC traces ([A], scale bar, 25 pA, 250 ms) and cumulative distributions showing that shRNA-mediated knockdown of
SAP-102 in PSD-952/2/PSD-932/2 mouse slice culture reduced the mEPSC amplitude ([B], n = 13) and frequency ([C], n = 13). Error bars = SEM.
(D1–D3) shRNA of SAP-102 in pyramidal neurons from PSD-952/2/PSD-932/2mice reduces AMPA-R EPSCs, but not IPSCs. (D1) Traces of evoked
EPSCs (downward deflection) and IPSC (upward deflection) from an uninfected neuron (left) and a neighbor expressing SAP-102 shRNA (middle).
Overlay inset shows the evoked EPSCs on a larger scale. (D2 and D3) Distributions of EPSCs showing that SAP-102 shRNA expression reduces
AMPA-R EPSC (D2) but has no effect on GABAA IPSCs (D3). Open and filled circles represent amplitudes for single pairs and mean 6 SEM,
respectively. Scale bar, 50 pA, 50 ms. Inset scale bar, 10 pA, 25 ms.reduction in AMPA-R EPSCs with a concomitant de-
crease in mEPSC frequency. Taken together with our
findings in the PSD-952/2/PSD-932/2 mouse (see be-
low), these results raised the possibility that PSD-95
and PSD-93 determine the synaptic targeting of most,
if not all, AMPA-Rs at mature synapses. Indeed, simulta-
neous shRNA-mediated knockdown of PSD-95 and
PSD-93 had additive effects, reducing AMPA-R trans-
mission by substantially more than 50%.
Single shRNA for PSD-95 or PSD-93 selectively re-
duces AMPA-R transmission, whereas simultaneous
double shRNA reduces both AMPA-R and NMDA-R
EPSCs. A number of control experiments established
that this reduction in the NMDA-R EPSC was specific.
This suggests that PSD-95 and PSD-93 are key struc-
tural scaffolding elements of the PSD jointly required
for proper synaptic expression of NMDA receptors.
The loss of synaptic AMPA-Rs induced by knockdown
of PSD-95 was accompanied by an increase in the num-
ber of AMPA-Rs on extrasynaptic membranes, whereas
the accumulation of synaptic AMPA-Rs with PSD-95
overexpression diminished extrasynaptic receptors
(Schnell et al., 2002). This highlights the dynamic ex-
change of AMPA-Rs between the synaptic and extra-
synaptic compartments.
Targeted Gene Knockout of PSD-95 and PSD-93
We have examined synaptic transmission in the hip-
pocampus of mice lacking PSD-95 protein (Yao et al.,
2004). As previously found in mice that express a trun-
cated PSD-95 (Migaud et al., 1998), we found no defect
in excitatory transmission in PSD-952/2 mice com-
pletely lacking PSD-95 protein. We have also studiedsynaptic transmission in the hippocampus in the PSD-
932/2mouse (McGee et al., 2001) and found that synap-
tic transmission is normal. Given the findings with
shRNA, these negative results strongly imply that com-
pensation occurs in the case of loss of a single PSD-
MAGUK. Indeed, AMPA-R-mediated synaptic transmis-
sion in the PSD-952/2/PSD-932/2 mouse was reduced
by 55%. As in the shRNA experiments, the defect in syn-
aptic transmission was due to the all-or-none silencing
of a population of synapses.
What might account for the remaining synaptic trans-
mission in the absence of PSD-95 and PSD-93? Knock-
down of SAP-102 in the PSD-952/2/PSD-932/2 mouse
removed 53% of the remaining synaptic transmission.
In this situation, the NMDA-R EPSC was also reduced,
but not to the same extent as the AMPA-R EPSC. Con-
sidering that transmission is reduced by 55% in the dou-
ble KO, the remaining transmission in cells expressing
shRNA for SAP-102 is only w15% of normal. These re-
sults suggest that nearly all synaptic AMPA-Rs require
a PSD-MAGUK for proper synaptic targeting.
PSD-MAGUK-Dependent AMPA-R Synaptic
Targeting Is Developmentally Regulated
The role of various PSD-MAGUKs in synapse develop-
ment is controversial. In dissociated neuronal cultures
PSD-95 is reported to be the first PSD-MAGUK scaf-
folding protein present at nascent postsynaptic sites
(El-Husseini et al., 2000; Rao et al., 1998). However,
other studies in intact brain suggest that PSD-95 is pres-
ent at low levels in the early postnatal period, while
SAP-102 is expressed at high levels (Sans et al., 2000).
We have found that at early stages of synaptic
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of PSD-95 and PSD-93 in Single Neurons
(A) DIC image of a hippocampal pyramidal
neuron (left, white arrow) doubly infected
with Lentivirus encoding PSD-93 shRNA
with EGFP and PSD-95 shRNA with dsRed.
Merged EGFP and dsRed fluorescent images
shown on the right. Scale bar, 50 mm. (B1 and
C1) Traces of evoked EPSCs from an unin-
fected neuron (top) and a neighbor doubly ex-
pressing PSD-95 and PSD-93 shRNA (middle)
in (B1) wild-type rat and (C1) PSD-952/2/
PSD-932/2 mouse slice culture. Scale bar,
50 pA, 50 ms. For scatter plots open and filled
circles represent amplitudes for single pairs
and mean 6 SEM, respectively. (B2–B3)
EPSC amplitudes show a large reduction in
the AMPA-R EPSC (B2) and a small reduction
in the NMDA-R EPSC (B3) in wild-type slices.
(C2–C3) Distribution of EPSCs showing no
effect of simultaneous PSD-95 and PSD-93
shRNA expression on AMPA-R or NMDA-R
EPSC amplitudes in PSD-952/2/PSD-932/2
mouse slices.differentiation, transmission does not require either
PSD-95 or PSD-93. Rather, SAP-102 mediates synaptic
AMPA-R clustering in neonates. This is consistent with
the developmental expression of PSD-MAGUKs in the
hippocampus. We know that the effect of acute knock-
down of SAP-102 on AMPA-R-mediated transmission
is specific because NMDA receptor transmission is not
affected. This suggests that SAP-102 is necessary for
AMPA-R trafficking to synapses that have already
been formed and contain only NMDA receptors. The
functional relevance of the developmental switch in
PSD-MAGUK-
dependent AMPA-R trafficking remains unclear. PSD-
MAGUKs differ in their ability to interact with synaptic
proteins. Presumably these differential binding abilities
confer specific functions, independent of AMPA-R
trafficking.
How Do PSD-MAGUKs Traffic AMPA-Rs?
Since most PSD-MAGUKs do not bind directly to AMPA-
Rs, an intermediary protein must be involved. We previ-
ously showed that the transmembrane protein stargazin
and other members of the TARP family likely serve this
role (Chen et al., 2000; Schnell et al., 2002; Tomita
et al., 2003). TARPs bind directly to AMPA-Rs and to
the first two PDZ domains of PSD-MAGUKs. It will be in-teresting to determine how general the PSD-MAGUK-
TARP trafficking mechanism is at other synapses in
the central nervous system. What holds PSD-MAGUKs
at the PSD? There are a number of candidates, but re-
cent attention has focused on neuroligins, which are
transmembrane cell adhesion proteins, that bind PSD-
MAGUKs and are implicated in early steps of synapse
formation (Chih et al., 2005; Graf et al., 2004; Irie et al.,
1997; Nam and Chen, 2005). However, the fact that neu-
roligins bind to the third PDZ domain, whereas targeting
of PSD-95 relies only on the first two PDZ domains (Cra-
ven et al., 1999), casts doubt on their role in AMPA-R
clustering.
A number of issues remain to be addressed. We have
found that, except for SAP-97, the other PSD-MAGUKs
appear to function in a similar manner. What advantage
is conferred by this redundancy? One obvious advan-
tage is robustness; if one member of the family is lost,
the synapses can still function. Might different PSD-
MAGUKs have distinct effects on other processes in-
volved in synaptic function? Most evidence in this and
previous studies emphasizes a role of PSD-MAGUKs in
the constitutive trafficking of AMPA-Rs. Might the
PSD-MAGUK-dependent trafficking be activity depen-
dent? Previous results examining the effects of palmi-
toylation of PSD-95 suggest that this may be the case
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(A) P8 PSD-952/2/PSD-932/2 and PSD-95+/2/PSD-932/+ littermates are not obviously different in size (U.S. dime shown for size reference).
(B) (Top) NMDA-R and AMPA-R EPSCs from representative cells from PSD-952/2/PSD-932/2 and controls. Scale bar, 25 pA, 50 ms. (Bottom)
Summary bar graphs showing no significant difference in the AMPA/NMDA EPSC ratio (controls: 0.19 6 0.03, n = 21; PSD-952/2/PSD-932/2:
0.17 6 0.02, n = 13; p = 0.75).
(C–E) mEPSC sample traces ([C], scale bar: 25 pA, 250 ms) and probability distributions showing no change in mEPSC amplitude (D) or mEPSC
frequency (E) (controls: n = 17; PSD-952/2/PSD-932/2: n = 12).
(F1–G3) Open and filled circles represent amplitudes for single pairs and mean 6 SEM, respectively. (F1) Traces of evoked EPSCs from an un-
infected neuron (left) and a neighbor expressing PSD-95 shRNA (middle) in wild-type immature slice cultures. Scale bar, 25 pA, 50 ms. Distribu-
tions of EPSC amplitudes show no significant difference in the AMPA-R EPSC (F2) or NMDA-R EPSC (F3). (G1) Traces of evoked EPSCs from an
uninfected P8 neuron (top) and a neighbor infected with SAP-102 shRNA (middle) in wild-type immature slice cultures. Scale bar, 20 pA, 50 ms.
Distributions of EPSC amplitudes show a significant reduction in the AMPA-R EPSC in cells expressing SAP-102 shRNA (G2) with no change in
the NMDA-R EPSC (G3).(El-Husseini Ael et al., 2002) and that the enhancement in
synaptic transmission caused by overexpression of
PSD-95 occludes long-term potentiation (LTP) and en-hances long-term depression (LTD) (Ehrlich and Mali-
now, 2004; Stein et al., 2003). It will be interesting to de-
termine whether endogenous PSD-MAGUKs have a role
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rectional synaptic plasticity. If so, it will be of interest to
determine how CaMKII, a key kinase involved in LTP,
regulates PSD-MAGUK-dependent AMPA-R trafficking.
Experimental Procedures
Plasmid Constructs
shRNA oligonucleotides were inserted into pLLox3.7. The following
shRNA targeting sequences were used for PSD-95 TCACG
ATCATCGCTCAGTATA; PSD-93 GACTGCCTAGCCAAGGACTTA
(alternative sequence: CTCTATTGTTCGACTGTATAT; both se-
quences yielded similar results); SAP-102 CCAAGTCCATCGAAGC
ACTTA. For knockdown of SAP-102 in mouse, the following target-
ing sequence was used with comparable efficiency (data not
shown), with the single nucleotide difference indicated: CCAAGTC
CATTGAAGCACTTA. Targeting sequences for PSD-95 and PSD-93
completely overlap in mouse and rat; rat cDNAs of PSD-95,
PSD-93, SAP-97, and SAP-102 were inserted into pGWI vector.
Silent mutations in cDNA pointmutant constructs were generated
using QuickChangeII (Stratagene) following the manufacturer’s
instructions.
Antibodies
Mouse PSD-95 antibody was from ABR. Rabbit anti-GluR2/3 and
anti-GluR1 and mouse anti-GluR2 were obtained from Chemicon.
Mouse NR-1 antibody was from Pharmigen. Mouse Tubulin and
goat actin antibodies were from Santa Cruz. PSD-93 antibody was
from Zymed. Guinea pig SAP-102 was described in Firestein et al.
(1999). Rabbit SAP-97 antibody was described in Topinka and Bredt
(1998).
Overexpression
COS-7 cells were transfected with Lipofectamine 2000 with cDNA
expression vectors as well as corresponding shRNA vectors in a mo-
lar ratio of 1:3. Forty-eight hours after transfection cells were lysed
with SDS-PAGE sample buffer. Lysates were sonicated and dena-
tured at 67C for 10 min and analyzed by SDS-PAGE. Blots were
probed with antibodies PSD-95 (1:1000), PSD-93 (1:2000), SAP-97
(1:2000) and SAP-102 (1:2000). Actin served as a loading control
for each blot. Immunoreactivity was visualized with the ECL system
(Pierce).
Neuronal Culture and Transfection
Dissociated hippocampal neuron cultures were prepared as previ-
ously described (Craven et al., 1999). In short, embryonic day 18
(E18) rat pups were sacrificed, and hippocampi were isolated and di-
gested using papain protease. Neurons were dissociated and resus-
pended in Neurobasal medium containing B27, Glutamax, and anti-
biotics (all Invitrogen). Neurons were plated at 50K or 100K per cm2
on Poly-D-lysine-treated support. Hippocampal neurons were
transfected at DIV 14–16 with 0.5–1 mg pLLox3.7 vectors using
0.5–1 ml Lipofectamine 2000 (Invitrogen) and incubated for 5 more
days before analysis.
Immunocytochemistry and Surface GluR2 Staining
Transfected neurons were used for immunocytochemistry at DIV 14–
16+5. Neurons were fixed with 4% paraformaldehyde/4% sucrose in
PBS for 12 min on ice followed by 100% methanol for 10 min at
–20C, washed twice with PBS for 5 min on ice. Cells were permea-
bilized with 0.1% TritonX 100 in PBS for 10 min and washed with PBS
for 5 min. After blocking with normal goat serum (3%) in PBS for 1 hr,
the cells were incubated with mouse anti-PSD-95 (1:1000) and rabbit
anti-PSD-93 (1:1000) antibodies followed by Alexa 546 or 647 conju-
gated secondary antibodies (Molecular Probes). Images were cap-
tured with a laser scanning fluorescent microscope LSM510 (Carl
Zeiss) equipped with a 633 oil emersion objective. Colocalization
was analyzed using LSM510 analysis software. At least 500 PSD-
93 positive clusters were analyzed for PSD-95 colocalization in at
least seven independent cells per condition. Statistical significance
was determined by Student’s t test.
Surface GluR2 staining was performed as described in Wyszynski
et al. (2002). In short, surface GluR2 receptors were ‘‘live’’-labeledwith an antibody to an extracellular epitope of GluR2 (Chemicon)
by incubating neurons in conditioned medium for 15 min at 37C.
Neurons were fixed with 4% paraformaldehyde/4% sucrose/PBS
for 8 min and blocked with PBS containing 3% normal goat serum.
Surface GluR2 was visualized with Alexa 546 conjugated secondary
antibody. Stacks of fluorescent images were acquired with a LSM
Pascal confocal laser microscopy system (Carl Zeiss) with a 633
oil emersion objective. Quantification was carried out on proximal
dendrites in at least nine independent, transfected neurons. For
quantification of spine localization of surface GluR2 clusters, only
mushroom-shaped protrusions from the dendrite as visualized by
GFP expression were analyzed using LSM Pascal colocalization
analysis software. A spine was considered GluR2 positive if it colo-
calized with at least one surface GluR2 cluster. The total number of
spines along the analyzed dendrite was recorded. The length of
a given dendrite was measured using LSM Pascal analysis software
tools (Carl Zeiss). The number of spines was then normalized to
10 mm. Filopodia-like protrusions were excluded from the analysis.
At least 250 spines were analyzed under each condition. Total sur-
face GluR2 staining was assessed with the following criteria. Surface
GluR2 clusters colocalized with the GFP marker anywhere on the
dendrite were analyzed. The number of clusters along the dendrite
was counted and the length of the analyzed dendrite was measured
using LSM Pascal analysis software tools. The number of clusters
was normalized to 10 mm. At least 275 surface GluR2 clusters were
analyzed in each condition in at least nine independent neurons.
Statistical significance was determined by Student’s t test.
Lentivirus Production and Neuronal Infection
For Lentiviral particle production, HEK293T cells were cotransfected
with pLLox3.7 and helper vectors pDelta8.9 and pVSVg using Lipo-
fectamine 2000 (Invitrogen). Forty-eight hours after transfection, su-
pernatant was collected and concentrated by ultrafiltration in Centri-
con Plus 100 (Millipore). Particles were aliquoted and stored at
280C. Particle titer was determined by infection of HEK293T cells.
Forty-eight hours after infection, HEK293T cells were analyzed with
a FACScalibur flow cytometer to determine titer.
Dissociated hippocampal neurons (see above) were infected at
DIV 9–10 with MOI 2 and incubated for 6 more days in the presence
of 5-Fluorodeoxyuridine and Uridine (Sigma). This achieved about
70% of infection efficiency. Neurons were then lysed with SDS-
PAGE sample buffer. Lysates were analyzed with SDS-PAGE and
western blotting. Blots were probed with PSD-95, PSD-93,
SAP-97, and SAP-102 as described above as well as anti NR-1
(1:2000) and anti Tubulin (1:1000) as loading controls.
Brain Lysates and Solubilization
PSD-95/PSD-93 double knockout mice and littermate control ani-
mals were sacrificed and the hippocampus was isolated. Hippo-
campi were homogenized in 10 volumes H-Buffer (320 mM sucrose,
2 mM EDTA, 20 mM TrisHCl [pH 8.0], 1 mM PMSF). Homogenate was
centrifuged for 10 min at 1000 3 g. Supernatants S1 were used for
further experiments. For total protein extracts SDS was added to a
final concentration of 1% and agitated for 1 hr at 4C. Extracts
were sonicated and the protein concentration was determined by
Bradford assay. Twenty-five micrograms of total protein was loaded
per lane and analyzed by SDS-PAGE and western blotting. P2 crude
synaptosome fractions, prepared from the supernatant S1, were re-
suspended in an equal volume of TET buffer (1% TritonX 100, 2 mM
EDTA, 20 mM TrisHCl [ph 7.4], 1 mM PMSF) and agitated for 1 hr at
4C. Extracts were centrifuged at 100,0003 g for 1 hr. The superna-
tant is the TritonX 100 soluble fraction. The pellet was resuspended
in 0.1 vol of 1% SDS, 2 mM EDTA, and 20 mM TrisHCl (pH 7.4). Then
0.9 volume of TET buffer was added and the extracts agitated for
1 hr at 4C (Tomita et al., 2005). Protein concentration was deter-
mined by Bradford assay. Five micrograms of protein were loaded
per lane and analyzed by SDS-PAGE followed by western blotting.
Desitometric analysis was carried out using ImageJ software. Signif-
icance was determined by Student’s t test.
Electrophysiology in Acute Slices
Transverse hippocampal slices (300–400 mm thick) were prepared
from PSD-952/2, PSD-932/2, PSD-952/2/PSD-932/2, heterozygous,
and wild-type littermates (7–40 days old) as previously described
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to the genotype of the mice during fEPSP and AMPA/NMDA ratio ex-
periments (except while using PSD-952/2/PSD-932/2mice, which
were always clearly smaller than their littermate controls). Acute
recordings were done at room temperature (24C–28C). Perfusion
medium contained (in mM) 119 NaCl, 2.5 KCl, 1.3 MgSO4
(4 MgSO4, to measure AMPA/NMDA ratios and mEPSCs),
1 NaH2PO4, 26.2 NaHCO3, 11 glucose, 2.5 CaCl2 (4 CaCl2, for
AMPA/NMDA ratios and mEPSCs), and 0.1–0.15 picrotoxin, satu-
rated with 95% O2/5% CO2. Inputs from CA3 to CA1 were severed
to prevent propagation of epileptic form activity.
Field EPSP recordings were made in CA1 stratum radiatum follow-
ing stimulation of Schaffer collaterals with monopolar glass elec-
trodes filled with 1 M NaCl. Synaptic responses were recorded
with glass electrodes (3–5 MU) filled with 1 M NaCl using a Multi-
Clamp 700A amplifier (Axon Instruments). PPF was obtained by
delivering two stimuli at an interval of 40 ms. For experiments involv-
ing P30–40 animals, slices from each knockout genotype and con-
trol were interleaved in a given day. Thus, we generated complete
input-output curves for each knockout genotype with respective
control littermates. Statistical analyses showed no significant differ-
ence between control groups. Thus, we combined the controls and
compared knockout values to this pooled control value.
Somatic whole-cell voltage-clamp recordings were made from vi-
sually identified CA1 pyramidal neurons using 3–5 MU glass elec-
trodes filled with internal recording solution containing (in mM) 125
CsMeSO3, 2.5 CsCl, 7.7 TEA, 5 QX-314, 4 Mg-ATP, 0.3 Na-GTP, 20
HEPES, 8 NaCl, and 0.2 EGTA (or 10 BAPTA) (pH 7.2) at 280–290
mOsm. Series and input resistance were monitored, and cells in
which either parameter varied by 25% during a recording session
were discarded. AMPA-R and NMDA-R EPSCs were obtained by
evoking dual component responses while voltage-clamping neu-
rons at +40 mV. One hundred micromolar APV (or ten micromolar
CPP) was then added to obtain the pure AMPA-R EPSC, and the
NMDA-R component was derived by subtracting the AMPA-R
EPSC from the compound EPSC. Interstimulus interval was 10 s.
For experiments using BAPTA, responses were evoked 2 min after
establishing whole-cell configuration. For recordings not using
BAPTA, only cells in which the AMPA-R EPSC after NMDA-R block-
ade did not differ from baseline responses recorded at 270 mV be-
fore voltage-clamping at +40 mV were included in the final analysis.
For experiments involving P30–40 animals, we generated complete
AMPA/NMDA EPSC ratios for each knockout genotype with respec-
tive control littermates. Statistical analyses showed no significant
difference between control groups. Thus, we combined the controls
and compared knockout values to this pooled control value.
mEPSCs were recorded at 270 mV in the presence of 0.5 mM tetro-
dotoxin, 0.1–0.15 mM picrotoxin, and 50 mM sucrose to increase the
frequency of events. mEPSCs were analyzed off line with custom-
ized software using a threshold of 4 pA. All data are expressed as
mean 6 SEM. Statistical significance was determine using two-tail
unpaired t tests for between-group comparisons. For mEPSCs,
the statistical significance between distributions was determined
using Kolmogorov-Smirnov test.
Electrophysiology in Slice Culture
Standard procedures were used to prepare rat and mouse organo-
typic slice cultures from animals ranging from P2–9 (Schnell et al.,
2002; Stein et al., 2003). All RNAi slice culture experiments (except
those described in Figures 8F1–8G3) were carried out in mature sli-
ces (see Figure 9). Experiments described in Figures 8F1–8G3 were
carried out using immature slices (see Figure 9). All slice cultures
were injected near the pyramidal cell layer with shRNA-containing
Lentiviral particles at a titer ranging from 106–108 cfu/ml.
Synaptic responses were evoked from pairs of infected and unin-
fected neurons simultaneously by electrically stimulating a common
pathway with monopolar glass electrodes filled with external perfu-
sion medium (see below). Recordings were made from pairs of pyra-
midal neurons using 3–5 MU glass electrodes filled with an internal
solution containing (in mM) 115 CsMeSo3, 20 CsCl, 10 HEPES,
2.5 MgCl2, 4 Mg-ATP, 0.4 Na-GTP, 0.6 EGTA, and 5 QX-314 (pH
7.2) at 290–300 mOsm. For experiments described in Figures 6D1–
6D3 the following intracellular recording solution was used (in
mM): 107.5 Cs-gluconate, 20 HEPES, 0.2 EGTA, 8 Na-gluconate,8 TEA-Cl, 4 Mg-ATP, 0.3 Na3-GTP, and 5 QX-314 (pH 7.2) at 290
mOsm. External perfusion medium consisted of (in mM) 119 NaCl,
2.5 KCl, 4 MgSO4, 1 NaH2PO4, 26.2 NaHCO3, 11 glucose, and
4 CaCl2, saturated with 95% O2/5% CO2 and including 100–150
mM picrotoxin and 5–10 mM 2-Chloroadenosine to block inhibition
and suppress epileptic activity. Series and input resistance were
monitored and cells were discarded if they differed by more than
20%. AMPA-R EPSCs were evoked while voltage clamping cells at
270 mV, and the amplitude was determined by measuring the
peak of this response. NMDA-R EPSCs were obtained while voltage
clamping cells at +40 mV, and the magnitude was determined by
measuring the amplitude of the EPSCs 602100 ms after the shock
artifact. Statistical difference was determined using a two-tailed
paired t test.
mEPSCs were recorded at270 mV in the presence of 0.5 mM tetro-
dotoxin, 0.1–0.15 mM picrotoxin, and 50 mM sucrose to increase the
frequency of events (100 mM sucrose was added for experiments
described in Figures 6A–6C). mEPSCs were analyzed off line with
customized software using a threshold of 4 pA. For mEPSCs, statis-
tical significance between distributions was determined using a Kol-
mogorov-Smirnov test. Somatic outside-out patches were clamped
at 270 mV. AMPA-R currents were evoked by local application of
500 mM S-AMPA for 2 s in the presence of 100 mM cyclothiazide.
Minimal stimulation experiments were carried out as previously
described (Stein et al., 2003).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/2/307/DC1/.
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